Literature DB >> 7485627

Relapse and impairment in bipolar disorder.

M J Gitlin1, J Swendsen, T L Heller, C Hammen.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the outcome of bipolar disorder in the context of maintenance pharmacotherapy.
METHOD: Eighty-two bipolar outpatients were followed prospectively for a mean of 4.3 years (minimum of 2 years); symptom rating and psychosocial outcome scales were used, and pharmacotherapy was rated on a 5-point scale.
RESULTS: Despite continual maintenance treatment, survival analysis indicated a 5-year risk of relapse into mania or depression of 73%. Of those who relapsed, two-thirds had multiple relapses. Relapse could not be attributed to inadequate medication. Even for those who did not relapse, considerable affective morbidity was observed. A measure of cumulative affective morbidity appeared to be a more sensitive correlate of psychosocial functioning than was the number of relapses. Poor psychosocial outcome paralleled poor syndromal course. Poor psychosocial functioning, especially occupational disruption, predicted a shorter time to relapse. Depressions were most strongly related to social and family dysfunction.
CONCLUSIONS: Even aggressive pharmacological maintenance treatment does not prevent relatively poor outcome in a significant number of bipolar patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485627     DOI: 10.1176/ajp.152.11.1635

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  125 in total

1.  Bipolar affective disorder-left out in the cold. Too late for the national service framework but local initiatives may be possible.

Authors:  Richard Morriss; Max Marshall; Amanda Harris
Journal:  BMJ       Date:  2002-01-12

Review 2.  Functional impairment and cognition in bipolar disorder.

Authors:  C A Zarate; M Tohen; M Land; S Cavanagh
Journal:  Psychiatr Q       Date:  2000

3.  Psychosocial predictors of mood symptoms 1 year after acute phase treatment of bipolar I disorder.

Authors:  Lauren M Weinstock; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2010-03-12       Impact factor: 3.735

4.  Recovery from serious mental illness: trajectories, characteristics, and the role of mental health care.

Authors:  Carla A Green; Nancy A Perrin; Michael C Leo; Shannon L Janoff; Bobbi Jo H Yarborough; Robert I Paulson
Journal:  Psychiatr Serv       Date:  2013-12-01       Impact factor: 3.084

5.  Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression.

Authors:  Brent P Forester; David G Harper; Joanna Georgakas; Caitlin Ravichandran; Nethra Madurai; Bruce M Cohen
Journal:  J Clin Psychopharmacol       Date:  2015-06       Impact factor: 3.153

Review 6.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

7.  The pharmacogenetics of lithium response depends upon clinical co-morbidity.

Authors:  Troy Bremer; Cornelius Diamond; Rebecca McKinney; Tatyana Shehktman; Thomas B Barrett; Chris Herold; John R Kelsoe
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  Undiagnosed Bipolar Disorder: New Syndromes and New Treatments.

Authors:  Ira D Glick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

9.  Identification of targeted analyte clusters for studies of schizophrenia.

Authors:  Tammy M K Cheng; Yu-En Lu; Paul C Guest; Hassan Rahmoune; Laura W Harris; Lan Wang; Dan Ma; Victoria Stelzhammer; Yagnesh Umrania; Matt T Wayland; Pietro Lió; Sabine Bahn
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

Review 10.  Psychosocial interventions for children with early-onset bipolar spectrum disorder.

Authors:  Nicholas Lofthouse; Mary A Fristad
Journal:  Clin Child Fam Psychol Rev       Date:  2004-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.